Skip to main content

New Job, Same Blog

Three months ago I had the great fortune of being hired for a job that gives me a front-row seat to the world of biomedical technology commercialization. I now work as a Licensing Associate at UT Southwestern Medical Center's Office for Technology Development. UT Southwestern is one of Texas's premier biomedical research institutions, boasting five Nobel laureates (one now emeritus), 19 members of the National Academy of Sciences, and 12 Howard Hughes Medical Institute investigators. The Office for Technology Development manages the institution's efforts in commercializing new technologies developed by its researchers. As Licensing Associate I will be responsible for negotiating and drafting license agreements that grant external entities such as biotech, pharmaceutical, and research reagent companies the right to use and commercialize UT Southwestern-developed technologies. 

Will the nature of my blog change as a result of my new job? Not really. Much of the information I encounter day-to-day in my new job is privileged, so I'm not in a position to blog freely about particular deals I and my office are, were, or will be, involved in. I plan to keep concentrating my blogging efforts on extracting insights about the Texas biomedical industry from publicly available sources of data, with occasional posts highlighting individual people and organizations relevant to my blog's topic. That said, I hope that the blog will come to reflect the ever-increasing understanding of the technology commercialization process I hope I will gain as time progresses.


– Isamu Hartman, PhD







Comments

Post a Comment

Popular posts from this blog

Comics About Patents (A Work In Progress)

Back in January and February of 2018, I spent some time creating two four-panel comics about the process of 1) obtaining patent protection, and 2) monetizing those patent rights by licensing them. I drew the comics to serve as an illustration of concepts that I often find myself explaining to others in the course of my work. I've already shared these comics through  Twitter  and  Facebook  (click on either of link to see more of the creative process!). However, I thought I'd share them with my blog's readership as well. Please enjoy! I'm really hoping to reignite this project at some point in the future and create more episodes. (Click on the images below to enlarge) Episode 1: Episode 2: - Isamu Hartman
Post a Comment
Read more

The Big Fish: Texas-Based Biomedical Companies listed on NYSE and NASDAQ

[Monday, 22 April 2013:  I added Hanger Inc. (HGR, NYSE), an Austin-based prosthetics and orthotics company I had originally missed, to the list] [Thursday, 02 May 2013:  fixed the location of Hanger Inc. (HGR, NYSE) - changed from Dallas to Austin] I have another few posts coming up on Texas-based awardees of the SBIR program. But first, a quick digression. +Levi Shapiro  asked me the following question during a phone conversation we had earlier today:  who are the "Big Players" in the Texas biomedical industry that are listed in the major stock exchanges? I knew about Luminex (LMNX, NASDAQ) off the top of my head. Other than that, though, I really had no idea. Following the advice of +Lauren Nise  , I used LexisNexis (courtesy of the UT Dallas Eugene McDermott Library ) to generate a list of publicly traded biomedical companies headquartered in Texas that are listed in either NYSE or NASDAQ. Here are the companies I found: (Open spreadsheet as a se...
Post a Comment
Read more

Corporate Venture Capital at the Top 10 Pharma/Biotech Companies

Today I'm taking a step outside of Texas and looking at the world. Many large pharmaceutical and biotech firms maintain venture capital operations through which they invest in early-stage biomedical companies. I wanted to get a sense of what these biopharma corporate venture capital (CVC) funds are up to. Which companies have CVC funds? How active are they? What are their goals? What are they investing in? Background: general and sector-specific trends in venture capital In 2014 venture capital funding in the U.S. hit its highest annual mark since 2001, as investors participated in $47.3 billion across 3,617 deals . Within this trend Life Sciences was the second largest sector (behind only the Media and Entertainment sector) for 2014 in dollar terms with $8.6 billion invested in 789 deals, the highest level since 2007 . Corporate venture funding has followed similar trends:  2014 marked the strongest year for CVC activity since 2000 with $5.4 billion invested in U.S.-based co...
Post a Comment
Read more